Literature DB >> 27201236

The Economic Value of Vaccination: Why Prevention Is Wealth.

V Remy1, N Largeron1, S Quilici1, S Carroll2.   

Abstract

Year:  2014        PMID： 27201236     DOI： 10.1016/j.jval.2014.08.1211

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  7 in total

1.  Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase.

Authors:  Catherine Mark; Sumit Gupta; Angela Punnett; Julia Upton; Julia Orkin; Adelle Atkinson; Lindsay Clarke; Alice Heisey; Christine McGovern; Sarah Alexander
Journal:  Pediatr Blood Cancer       Date:  2021-08-16       Impact factor: 3.838

2.  The Determinants of Vaccine Literacy in the Italian Population: Results from the Health Literacy Survey 2019.

Authors:  Chiara Cadeddu; Luca Regazzi; Guglielmo Bonaccorsi; Aldo Rosano; Brigid Unim; Robert Griebler; Thomas Link; Paola De Castro; Roberto D'Elia; Valeria Mastrilli; Luigi Palmieri
Journal:  Int J Environ Res Public Health       Date:  2022-04-07       Impact factor: 4.614

3.  Pharmacists as Immunizers: The Role of Pharmacies in Promoting Immunization Campaigns and Counteracting Vaccine Hesitancy.

Authors:  Nicola Luigi Bragazzi
Journal:  Pharmacy (Basel)       Date:  2019-12-05

Review 4.  Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges.

Authors:  Idris Nasir Abdullahi; Anthony Uchenna Emeribe; Hafeez Aderinsayo Adekola; Sharafudeen Dahiru Abubakar; Amos Dangana; Halima Ali Shuwa; Sunday Theophilus Nwoba; Jelili Olaide Mustapha; Muyideen Titilope Haruna; Kafayat Adepeju Olowookere; Olawale Sunday Animasaun; Charles Egede Ugwu; Solomon Oloche Onoja; Abdullahi Sani Gadama; Musa Mohammed; Isa Muhammad Daneji; Dele Ohinoyi Amadu; Peter Elisha Ghamba; Nkechi Blessing Onukegbe; Muhammad Sagir Shehu; Chiladi Isomah; Adamu Babayo; Abdurrahman El-Fulaty Ahmad
Journal:  Hum Vaccin Immunother       Date:  2020-09-16       Impact factor: 3.452

5.  Measuring "Fearonomic Effects" in Valuing Therapies: An Application to COVID-19 in China.

Authors:  Siyu Ma; David D Kim; Joshua T Cohen; Peter J Neumann
Journal:  Value Health       Date:  2020-07-27       Impact factor: 5.725

6.  Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2.

Authors:  Mariangela Garofalo; Monika Staniszewska; Stefano Salmaso; Paolo Caliceti; Katarzyna Wanda Pancer; Magdalena Wieczorek; Lukasz Kuryk
Journal:  Vaccines (Basel)       Date:  2020-06-10

Review 7.  Challenges and prospects of COVID-19 vaccine development based on the progress made in SARS and MERS vaccine development.

Authors:  Jubeda Begum; Nasir Akbar Mir; Kapil Dev; Bidyarani Buyamayum; Mohd Yaqoob Wani; Meesam Raza
Journal:  Transbound Emerg Dis       Date:  2020-09-23       Impact factor: 4.521
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.